KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Feb 20, 2019 $1.44 $1.53 $1.31 $1.38 3 908
Feb 19, 2019 $1.40 $1.44 $1.39 $1.44 2 483
Feb 15, 2019 $1.41 $1.44 $1.38 $1.39 967
Feb 14, 2019 $1.61 $1.61 $1.38 $1.38 21 849
Feb 13, 2019 $1.53 $1.55 $1.53 $1.55 890
Feb 12, 2019 $1.57 $1.57 $1.49 $1.49 2 621
Feb 11, 2019 $1.41 $1.59 $1.41 $1.45 1 901
Feb 08, 2019 $1.54 $1.61 $1.49 $1.53 4 857
Feb 07, 2019 $1.40 $1.50 $1.39 $1.45 7 338
Feb 06, 2019 $1.40 $1.40 $1.39 $1.39 399
Feb 05, 2019 $1.39 $1.39 $1.27 $1.39 3 916
Feb 04, 2019 $1.40 $1.40 $1.34 $1.39 7 506
Feb 01, 2019 $1.59 $1.59 $1.15 $1.33 24 404
Jan 31, 2019 $1.50 $1.62 $1.50 $1.61 2 079
Jan 30, 2019 $1.55 $1.65 $1.49 $1.57 6 412
Jan 29, 2019 $1.47 $1.48 $1.44 $1.47 3 733
Jan 28, 2019 $1.41 $1.41 $1.41 $1.41 1 055
Jan 25, 2019 $1.46 $1.48 $1.41 $1.47 1 429
Jan 24, 2019 $1.44 $1.49 $1.37 $1.49 6 428
Jan 23, 2019 $1.45 $1.45 $1.45 $1.45 2 859
Jan 22, 2019 $1.50 $1.55 $1.44 $1.46 6 832
Jan 18, 2019 $1.47 $1.47 $1.43 $1.46 2 478
Jan 17, 2019 $1.33 $1.55 $1.33 $1.49 4 803
Jan 16, 2019 $1.33 $1.47 $1.31 $1.32 4 216
Jan 15, 2019 $1.49 $1.51 $1.30 $1.38 9 195
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT